The results of studies confirming a high efficacy of PCSK9 inhibitors administered immediately after an ACS (the EVOPACS and EVACS studies with evolocumab [179, 180] and the VCU-alirocRT study with alirocumab [181]) are also worth noting, as they were the starting point for recommendation concerning initiation of treatment with PCSK9 inhibitors during hospitalisation (recommendation level IIa C) in the most recent ESC/EAS 2019 guidelines [9]
Abstract Dysregulation of nutrient homeostasis is implicated in the current epidemics of obesity and type 2 diabetes mellitus
When looking at the real-world results of glutathione vs Vitamin C or oral capsules, the clinical advantage of injections is often clear
The timing of doses can matter in some cases
Carlat Verdict: To prevent metabolic side effects when beginning an antipsychotic, start with metformin, but consider a GLP-1 RA for patients who have already been on antipsychotics for a while with a BMI 30 kg/m 2 (or 27 kg/m 2 and obesity-related health problems)
I hope that you're not as sensitive as I am and that it goes away faster